Compare Moderna, Inc. (MRNA) vs Stitch Fix Inc (SFIX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs Stitch Fix Inc — how do they compare? Moderna, Inc. trades at $61.76 (market cap $24.18B), while Stitch Fix Inc trades at $3.63 (market cap $497.68M). The key difference: Moderna, Inc. is far larger — about 48.6× Stitch Fix Inc's market cap, and Moderna, Inc. is trading nearer its 52-week high, Stitch Fix Inc nearer its low. Which is the better fit depends on your goals.
| MRNA | SFIX | |
|---|---|---|
Market Cap | $24.18B | $497.68M |
Sector | Health | Consumer Cyclical |
52-Week High | $81.80 | $5.83 |
52-Week Low | $22.36 | $3.06 |
Enterprise Value | $20.33B | $385.40M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Moderna (MRNA) trades at $59.81, up 1.08% today, with a bullish technical signal from moving averages and recent FDA approval for its mRNA flu vaccine mFLUSIVA. Despite beating Q2 2026 EPS estimates, revenue has declined from pandemic peaks, with a net income margin of -142.58% in 2026. The stock faces resistance near $61-$63, while support lies at $56-$59.
Outlook remains mixed; pipeline advancements in flu, Ebola, and oncology offer growth potential, but persistent losses and high valuation ratios pose risks. Analyst consensus is cautious with a $54.33 price target below current levels, reflecting concerns over profitability amid transitioning business focus.
Stitch Fix (SFIX) trades at $3.97, down 5.48% today, as the online personal styling service shows mixed signals. While revenue has stabilized around $1.3B annually and losses are narrowing significantly, the company remains unprofitable with a -1.43% net margin. Technical indicators show a bullish trend with strong momentum signals, though oscillators remain neutral. Recent news highlights AI-driven personalization initiatives and active client growth as potential turnaround catalysts.
The stock presents a speculative recovery opportunity with improving fundamentals but carries execution risks. Analyst consensus is cautious with a $4.75 price target (20% upside) but only 27% buy ratings. Key risks include consumer spending pressure and the challenge of achieving sustainable profitability in the competitive retail sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About Stitch Fix Inc
Stitch Fix Inc offers personal style service for men and women. The company engages in delivering one-to-one personalization to clients through the combination of data science and human judgment. It provides a shipment service called A FIX where the stylist's hand selects items from several merchandises with analysis of client and merchandise data to provide a personalized shipment of apparel, shoes, and accessories suited to the client's needs. The company offers products across categories, brands, product types and price points including Women's, Petite, Maternity, Men's and Plus. It also offers various product types, including denim, dresses, blouses, skirts, shoes, jewelry and handbags, and sells merchandise across various range of price points.
Read more on SFIX →
